Adhesion molecules in inflammatory bowel disease

Therapeutic implications for gut inflammation

S. Danese, S. Semeraro, M. Marini, I. Roberto, A. Armuzzi, A. Papa, A. Gasbarrini

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Mucosal endothelium has become one of the major areas of investigation in gut inflammation. It is now well recognised that it plays an active role in the pathogenesis of both forms of inflammatory bowel disease, Crohn's disease and ulcerative colitis, since endothelial cells regulate mucosal immune homeostasis, acting as "gatekeepers", controlling leukocyte accumulation in the interstitial compartment. This process is mediated by leukocyte-endothelial adhesion molecules. This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease.

Original languageEnglish
Pages (from-to)811-818
Number of pages8
JournalDigestive and Liver Disease
Volume37
Issue number11
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Inflammatory Bowel Diseases
Leukocytes
Inflammation
Cell Adhesion Molecules
Ulcerative Colitis
Crohn Disease
Endothelium
Homeostasis
Endothelial Cells
Clinical Trials
Therapeutics

Keywords

  • Adhesion molecules
  • Endothelium
  • Leukocyte

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Adhesion molecules in inflammatory bowel disease : Therapeutic implications for gut inflammation. / Danese, S.; Semeraro, S.; Marini, M.; Roberto, I.; Armuzzi, A.; Papa, A.; Gasbarrini, A.

In: Digestive and Liver Disease, Vol. 37, No. 11, 11.2005, p. 811-818.

Research output: Contribution to journalArticle

Danese, S, Semeraro, S, Marini, M, Roberto, I, Armuzzi, A, Papa, A & Gasbarrini, A 2005, 'Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation', Digestive and Liver Disease, vol. 37, no. 11, pp. 811-818. https://doi.org/10.1016/j.dld.2005.03.013
Danese, S. ; Semeraro, S. ; Marini, M. ; Roberto, I. ; Armuzzi, A. ; Papa, A. ; Gasbarrini, A. / Adhesion molecules in inflammatory bowel disease : Therapeutic implications for gut inflammation. In: Digestive and Liver Disease. 2005 ; Vol. 37, No. 11. pp. 811-818.
@article{7ae20e10e3da4b7d9c36a793682bc10a,
title = "Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation",
abstract = "Mucosal endothelium has become one of the major areas of investigation in gut inflammation. It is now well recognised that it plays an active role in the pathogenesis of both forms of inflammatory bowel disease, Crohn's disease and ulcerative colitis, since endothelial cells regulate mucosal immune homeostasis, acting as {"}gatekeepers{"}, controlling leukocyte accumulation in the interstitial compartment. This process is mediated by leukocyte-endothelial adhesion molecules. This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease.",
keywords = "Adhesion molecules, Endothelium, Leukocyte",
author = "S. Danese and S. Semeraro and M. Marini and I. Roberto and A. Armuzzi and A. Papa and A. Gasbarrini",
year = "2005",
month = "11",
doi = "10.1016/j.dld.2005.03.013",
language = "English",
volume = "37",
pages = "811--818",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "11",

}

TY - JOUR

T1 - Adhesion molecules in inflammatory bowel disease

T2 - Therapeutic implications for gut inflammation

AU - Danese, S.

AU - Semeraro, S.

AU - Marini, M.

AU - Roberto, I.

AU - Armuzzi, A.

AU - Papa, A.

AU - Gasbarrini, A.

PY - 2005/11

Y1 - 2005/11

N2 - Mucosal endothelium has become one of the major areas of investigation in gut inflammation. It is now well recognised that it plays an active role in the pathogenesis of both forms of inflammatory bowel disease, Crohn's disease and ulcerative colitis, since endothelial cells regulate mucosal immune homeostasis, acting as "gatekeepers", controlling leukocyte accumulation in the interstitial compartment. This process is mediated by leukocyte-endothelial adhesion molecules. This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease.

AB - Mucosal endothelium has become one of the major areas of investigation in gut inflammation. It is now well recognised that it plays an active role in the pathogenesis of both forms of inflammatory bowel disease, Crohn's disease and ulcerative colitis, since endothelial cells regulate mucosal immune homeostasis, acting as "gatekeepers", controlling leukocyte accumulation in the interstitial compartment. This process is mediated by leukocyte-endothelial adhesion molecules. This paper reviews the major molecules that mediate leukocyte-endothelial interactions, and summarises the results of the most recent clinical trials targeting adhesion molecules in inflammatory bowel disease.

KW - Adhesion molecules

KW - Endothelium

KW - Leukocyte

UR - http://www.scopus.com/inward/record.url?scp=33644875407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644875407&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2005.03.013

DO - 10.1016/j.dld.2005.03.013

M3 - Article

VL - 37

SP - 811

EP - 818

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 11

ER -